National Institute of Health-Grants

Notice to Extend the Expiration Date of PA-24-248 PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)

Published: 31 March 2025
Categories: National Institute of Health-Grants

RSS feed source: National Institute of Health

Notice to Extend the Expiration Date of PA-24-248 PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)

The purpose of this notice is to Extend the Expiration Date of PA-24-248 PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) by one receipt date. PA-24-248 will now expire on September 6, 2025.

Due to the extension, the following dates will be added:

Standard application due date : September 5, 2025
Scientific Merit Review: November 2025
Advisory Council: January 2026

The following sections of the FOA have been changed:

Part 1. Overview Information, Key Dates

Currently reads:

Application Due DatesReview and Award CyclesNewRenewal / Resubmission / Revision (as allowed)AIDS – New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start DateSeptember 05, 2024 *September 05, 2024 *Not

Click this link to continue reading the article on the source website.

Notice to Extend the Expiration Date of PA-24-247 PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)

Published: 31 March 2025
Categories: National Institute of Health-Grants

RSS feed source: National Institute of Health

Notice to Extend the Expiration Date of PA-24-247 PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)

The purpose of this notice is to extend the expiration date of PA-24-247 PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) by one receipt date. PA-24-247 will now expire on September 6, 2025.

Due to the extension, the following dates will be added:

Standard application due date : September 5, 2025
Scientific Merit Review: November 2025
Advisory Council: January 2026

The following sections of the FOA have been changed:

Part 1. Overview Information, Key Dates

Currently reads:

Application Due DatesReview and Award CyclesNewRenewal / Resubmission / Revision (as allowed)AIDS – New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start DateSeptember 05, 2024 *September 05,

Click this link to continue reading the article on the source website.

Notice to Extend the Expiration Date of PA-24-246 PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)

Published: 31 March 2025
Categories: National Institute of Health-Grants

RSS feed source: National Institute of Health

Notice to Extend the Expiration Date of PA-24-246 PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)

The purpose of this notice is to extend the expiration date of PA-24-246 PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) by one receipt date. PA-24-246 will now expire on September 6, 2025.

Due to the extension, the following dates will be added:

Standard application due date : September 5, 2025
Scientific Merit Review: November 2025
Advisory Council: January 2026

The following sections of the FOA have been changed:

Part 1. Overview Information, Key Dates

Currently reads:

Application Due DatesReview and Award CyclesNewRenewal / Resubmission / Revision (as allowed)AIDS – New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start DateSeptember 05, 2024

Click this link to continue reading the article on the source website.

Notice to Extend the Expiration Date of PA-24-245 PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

Published: 31 March 2025
Categories: National Institute of Health-Grants

RSS feed source: National Institute of Health

Notice to Extend the Expiration Date of PA-24-245 PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

The purpose of this notice is to extend the expiration date of PA-24-245 PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) by one receipt date. PA-24-245 will now expire on September 6, 2025.

Due to the extension, the following dates will be added:

Standard application due date : September 5, 2025
Scientific Merit Review: November 2025
Advisory Council: January 2026

The following sections of the NOFO have been changed:

Part 1. Overview Information, Key Dates

Currently reads:

Application Due DatesReview and Award CyclesNewRenewal / Resubmission / Revision (as allowed)AIDS – New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest

Click this link to continue reading the article on the source website.